SG/CALL/ZOETIS/200/0.1/20.12.24 Stock

Warrant

DE000SU2YLB4

Market Closed - Boerse Frankfurt Warrants 03:40:21 2024-05-17 pm EDT
0.83 EUR -1.19% Intraday chart for SG/CALL/ZOETIS/200/0.1/20.12.24
Current month+40.00%
1 month+140.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 0.84 0.00%
24-05-16 0.84 +2.44%
24-05-15 0.82 +13.89%
24-05-14 0.72 +2.86%
24-05-13 0.7 -2.78%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 03:40 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ZOETIS INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SU2YLB
ISINDE000SU2YLB4
Date issued 2023-11-29
Strike 200 $
Maturity 2024-12-20 (217 Days)
Parity 10 : 1
Emission price 1.51
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.64
Lowest since issue 0.23
Spread 0.01
Spread %1.20%

Company Profile

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Sector
-
More about the company

Ratings for Zoetis Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Zoetis Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
174.1 USD
Average target price
211.2 USD
Spread / Average Target
+21.34%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW